The objective of this study was to assess the influence of oral contraceptives (OCs) on the
risk of venous thromboembolism (VTE) in young women. A 5-year case-control study …

To assess the influence of oral contraceptives (OC) on the risk for venous thromboembolism
(VTE) in young women, a 5-year case-control study including all women 15–44 years old …

Background Four studies published since December, 1995, reported that the incidence of
venous thromboembolism (VTE) was higher in women who used oral contraceptives (OCs) …

Background and purpose of the workshop Concern about the venous thromboembolism
(VTE) risk of new hormonal contraceptive options shortly after their entry into the market has …

Background: An association between oral contraceptive (OC) use and venous
thromboembolism (VTE) has long been recognized. However, no summary estimates of the …

Recent epidemiologic studies reported that the risk of venous thromboembolism (VTE) was
higher with the use of the newer third generation oral contraceptives than with second …

CONTEXT: Previous studies have reported that users of the “third-generation” oral
contraceptives (OCs) containing the progestins gestodene and desogestrel have about …

Objectives: The study was intended to evaluate the effects of oral contraceptives and
smoking on the risks of arterial and venous thromboembolic diseases among young women …

A matched case-control study was undertaken in 10 centers in Germany and the United
Kingdom to explore the association of current use of major combination oral contraceptives …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …